These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7671093)

  • 1. Diagnosis and treatment of calcium kidney stones.
    Klugman V; Favus MJ
    Adv Endocrinol Metab; 1995; 6():117-42. PubMed ID: 7671093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-Hour Urinary Chemistries and Kidney Stone Risk.
    Ferraro PM; Taylor EN; Curhan GC
    Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic hypercalciuria and formation of calcium renal stones.
    Coe FL; Worcester EM; Evan AP
    Nat Rev Nephrol; 2016 Sep; 12(9):519-33. PubMed ID: 27452364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
    Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
    Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
    Schmiedl A; Schwille PO
    Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
    Solak V; Gökce Mİ; Yaman Ö
    Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietetic and lifestyle recommendations for stone formers.
    Ferraro PM; Bargagli M
    Arch Esp Urol; 2021 Jan; 74(1):112-122. PubMed ID: 33459627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.